Article
Cryo-EM structure of human LRRC15 reveals the basis of therapeutic antibody recognition
2026-06-18
Abstract excerpt
Leucine-rich repeat containing 15 (LRRC15) is a structural uncharacterised membrane protein, which is highly upregulated in cancer-associated fibroblasts and enriched in desmoplastic tumours including pancreatic, breast and head-and-neck cancers, where it is associated with therapy resistance. The LRRC15-targeting antibody-drug conjugate samrotamab vedotin has advanced into Phase I clinical evaluation, yet mechani...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0fca149a-911f-5bf9-b43c-8d48e01cfa83
- DOI
- 10.64898/2026.06.16.732218
